Kelly Schick
Förmögenhet: 508 493 $ per 2026-06-30
Förmögenhet: 508 493 $ per 2026-06-30
Kelly A. Schick is Vice President-Account Management at ScripNet LLC since 2012.
Ms. Schick is Chief People Officer at C4 Therapeutics, Inc. since 2021.
Former roles include Head-Global Talent at Bristol Myers Squibb Co. and Chief Human Resources Officer & Senior VP at AMAG Pharmaceuticals, Inc. Education includes undergraduate studies at Boston University and graduate studies at The Curtis L.
Carlson School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-14 | 108 885 ( 0,1 % ) | 508 493 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Personalchef | 2021-01-12 |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services Provides pharmacy benefit management electronic processing services | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | - |
| AMAG PHARMACEUTICALS, INC. | Personalchef | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services Provides pharmacy benefit management electronic processing services | Technology Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Curtis L. Carlson School of Management
The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån